Harvard Bioscience Files 2024 10-K
Ticker: HBIO · Form: 10-K · Filed: Mar 14, 2025 · CIK: 1123494
| Field | Detail |
|---|---|
| Company | Harvard Bioscience Inc (HBIO) |
| Form Type | 10-K |
| Filed Date | Mar 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, financials
TL;DR
HBIO filed its 2024 10-K, check financials.
AI Summary
Harvard Bioscience Inc. filed its 10-K for the fiscal year ending December 31, 2024. The filing details the company's financial performance and operational segments. Key financial data and disclosures are provided for the reporting period.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Harvard Bioscience's financial health and strategic direction for the past fiscal year.
Risk Assessment
Risk Level: medium — The filing is a standard annual report and does not inherently indicate new risks.
Key Players & Entities
- HARVARD BIOSCIENCE INC (company) — Filer
- 2024-12-31 (date) — Fiscal Year End
- 2025-03-14 (date) — Filing Date
- 0001123494 (company) — Central Index Key
FAQ
What is Harvard Bioscience Inc.'s fiscal year end?
Harvard Bioscience Inc.'s fiscal year ends on December 31.
When was this 10-K filing submitted?
This 10-K filing was submitted on March 14, 2025.
What is the Central Index Key for Harvard Bioscience Inc.?
The Central Index Key for Harvard Bioscience Inc. is 0001123494.
What is the Standard Industrial Classification for Harvard Bioscience Inc.?
The Standard Industrial Classification for Harvard Bioscience Inc. is LABORATORY ANALYTICAL INSTRUMENTS [3826].
In which state was Harvard Bioscience Inc. incorporated?
Harvard Bioscience Inc. was incorporated in Delaware (DE).
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 14, 2025 regarding HARVARD BIOSCIENCE INC (HBIO).